Role evidence
Usage summary
Strongest role: Inclusion Required
Inclusion-required count: 45
Treatment-assignment count: 0
Stratification count: 0
Cdx Established Context
ALK fusion
NSCLC · Combination Therapy
ALK fusion is flagged as cdx established context because public trials show inclusion required evidence in 48 contexts. FDA CDx context exists.
Threshold snippets
Fragmentation view
Threshold count: 12
Common snippets: BRAF V600E | KRAS G12C | KRAS G12C
Threshold label: Moderate
FDA CDx context
Mapping summary
CDx label: Fda Cdx Context Exists
CDx maturity score: 5/5
Confidence: Medium
Patent-density signal
Diagnostic appendix
Signal count: 0
Recent signals: 0
Density label: Low
Source links
Evidence paths
https://clinicaltrials.gov/study/NCT01557959 | https://clinicaltrials.gov/study/NCT00031681 | https://clinicaltrials.gov/study/NCT01115803 | https://clinicaltrials.gov/study/NCT05241873 | https://clinicaltrials.gov/study/NCT02328105 | https://clinicaltrials.gov/study/NCT01798485 | https://clinicaltrials.gov/study/NCT02321501 | https://clinicaltrials.gov/study/NCT05500508 | https://clinicaltrials.gov/study/NCT06043973 | https://clinicaltrials.gov/study/NCT00577707 | https://clinicaltrials.gov/study/NCT07014202 | https://clinicaltrials.gov/study/NCT03775486 | https://clinicaltrials.gov/study/NCT02795884 | https://clinicaltrials.gov/study/NCT02277457 | https://clinicaltrials.gov/study/NCT06343064 | https://clinicaltrials.gov/study/NCT00965731 | https://clinicaltrials.gov/study/NCT07354061 | https://clinicaltrials.gov/study/NCT05200481 | https://clinicaltrials.gov/study/NCT04459663 | https://clinicaltrials.gov/study/NCT06746870 | https://clinicaltrials.gov/study/NCT04042558 | https://clinicaltrials.gov/study/NCT06196814 | https://clinicaltrials.gov/study/NCT03164616 | https://clinicaltrials.gov/study/NCT07198841 | https://clinicaltrials.gov/study/NCT07227025 | https://clinicaltrials.gov/study/NCT06970132 | https://clinicaltrials.gov/study/NCT04940637 | https://clinicaltrials.gov/study/NCT05346952 | https://clinicaltrials.gov/study/NCT03317496 | https://clinicaltrials.gov/study/NCT05568212 | https://clinicaltrials.gov/study/NCT05635708 | https://clinicaltrials.gov/study/NCT04776447 | https://clinicaltrials.gov/study/NCT03896074 | https://clinicaltrials.gov/study/NCT04832854 | https://clinicaltrials.gov/study/NCT06580665 | https://clinicaltrials.gov/study/NCT04167774 | https://clinicaltrials.gov/study/NCT05746481 | https://clinicaltrials.gov/study/NCT02888743 | https://clinicaltrials.gov/study/NCT04866017 | https://clinicaltrials.gov/study/NCT04105270 | https://clinicaltrials.gov/study/NCT05651022 | https://clinicaltrials.gov/study/NCT03475953 | https://clinicaltrials.gov/study/NCT03472560 | https://clinicaltrials.gov/study/NCT03836066 | https://clinicaltrials.gov/study/NCT01577654 | https://clinicaltrials.gov/study/NCT05800340 | https://clinicaltrials.gov/study/NCT03386929 | https://clinicaltrials.gov/study/NCT04323436